Testing a therapy for bipolar II depression
Treatments studied
Part of Mental health clinical trials.
This trial tests if a type of talk therapy (IPSRT) can help people with bipolar II disorder who are currently depressed. Participants must have irregular daily rhythms and be off psychiatric medications for at least 4 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old
- You have been diagnosed with bipolar II disorder and are currently having a major depressive episode
- You have not taken any psychiatric medication for at least 4 weeks
- You have irregular daily rhythms or sleep patterns
- You are of Han Chinese ethnicity and are right-handed
- You are able to read and complete questionnaires in Chinese
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is following and assessing people with major depression or bipolar disorder to better understand the condition and how the brain relates to symptoms. It may help researchers develop more targeted support by comparing brain and health information over time.
This trial tests a new type of brain stimulation called temporal interference stimulation to see if it can safely and effectively improve symptoms of bipolar depression. It may be an option for people who are not taking medication or who are willing to stop their current medication for a short time.
This trial tests an investigational drug called LB-102 for people with bipolar I disorder who are currently experiencing a major depressive episode without psychosis. It aims to see if the drug is safe and effective for treating depression symptoms.
This trial tests whether psilocybin (a substance found in certain mushrooms) given with therapy can help people with bipolar II disorder who are currently in a major depression that hasn't responded to other treatments. You'll receive the drug in a supportive setting, and researchers will follow your progress to see if it's safe and effective.
This trial tests an experimental pill (ABB-932) for people with bipolar I or II disorder who are currently in a depressive episode. The goal is to see if the drug is safe and helps improve mood.
This trial tests whether OSU6162 can improve depressive symptoms in adults with bipolar depression who are already taking a stable mood-stabilizing medicine. It also checks safety by closely monitoring mood, heart rhythm, and other health factors during the study.
Hear when a new Bipolar Disorder II trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.